NewsBenzingainTest T3 BPA ajusté de 0,18 $ dépasse l’estimation de 0,12 $, le chiffre d’affaires de 35,069 M$ dépasse l’estimation de 34,800 M$ inTest T3 BPA ajusté de 0,18 $ dépasse l’estimation de 0,12 $, le chiffre d’affaires de 35,069 M$ dépasse l’estimation de 34,800 M$ Benzinga 2026.11.06 11:16 (GMT+0) Open on Benzinga Other news Wells Fargo Maintains Overweight on Century Aluminum, Lowers Price Target to $71 B. Riley Securities Maintains Neutral on Alpha & Omega, Lowers Price Target to $22 Citizens Maintains Market Outperform on Inspired Entertainment, Lowers Price Target to $7 Wells Fargo Maintains Overweight on CRH, Raises Price Target to $107 Citizens Maintains Market Outperform on Halozyme Therapeutics, Raises Price Target to $149 Thermo Fisher Scientific Authorizes $5 Billion Share Buyback after Upbeat Earnings
